A Phase II Trial of Cremorphor EL-free Paclitaxel (Genexol-Pm) and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-014-2498-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Multi-Center, Phase II Trial of Nab-Paclitaxel and Gemcitabine in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Cancer Management and Research
Oncology
2019English

Phase I/Ii Trial of Pemetrexed Plus Nab-Paclitaxel in Advanced Solid Tumor Patients With Emphasis on Non-Small Cell Lung Cancer

Investigational New Drugs
OncologyPharmacology
2013English

Phase I and Pharmacokinetic Study of Genexol-Pm, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients With Advanced Malignancies

Clinical Cancer Research
Cancer ResearchOncology
2004English

Randomized Phase II Trial of Paclitaxel and Carboplatin Followed by Gemcitabine Switch-Maintenance Therapy Versus Gemcitabine and Carboplatin Followed by Gemcitabine Continuation-Maintenance Therapy in Previously Untreated Advanced Non-Small Cell Lung Cancer

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2013English

A Phase I Trial of Temsirolimus and Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer

Chemotherapy
MedicineDrug DiscoveryInfectious DiseasesOncologyPharmacology
2016English

A Phase I/Ii Study of Weekly Nab-Paclitaxel Plus Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small-Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Gemcitabine Plus Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Phase II Study of Three Different Doses

British Journal of Cancer
Cancer ResearchOncology
2000English

A Phase II Trial of Erlotinib Monotherapy for Pretreated Elderly Patients With Advanced EGFR Wild-Type Non-Small Cell Lung Cancer

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2015English

Phase II Study of Gemcitabine Plus Oxaliplatin as First-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy